Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

  1. Smyth, L.M.
  2. Batist, G.
  3. Meric-Bernstam, F.
  4. Kabos, P.
  5. Spanggaard, I.
  6. Lluch, A.
  7. Jhaveri, K.
  8. Varga, A.
  9. Wong, A.
  10. Schram, A.M.
  11. Ambrose, H.
  12. Carr, T.H.
  13. de Bruin, E.C.
  14. Salinas-Souza, C.
  15. Foxley, A.
  16. Hauser, J.
  17. Lindemann, J.P.O.
  18. Maudsley, R.
  19. McEwen, R.
  20. Moschetta, M.
  21. Nikolaou, M.
  22. Schiavon, G.
  23. Razavi, P.
  24. Banerji, U.
  25. Baselga, J.
  26. Hyman, D.M.
  27. Chandarlapaty, S.
  28. Show all authors +
Journal:
npj Breast Cancer

ISSN: 2374-4677

Year of publication: 2021

Volume: 7

Issue: 1

Type: Article

DOI: 10.1038/S41523-021-00251-7 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus